Veracyte Names Phillip G. Febbo, M.D., as Chief Scientific Officer and Chief Medical Officer

Veracyte, Inc. today announced that Phillip G. Febbo, M.D., will join the company on October 2 as chief scientific officer and chief medical officer. Dr. Febbo, a distinguished industry and academic...

Related Keywords

South San Francisco ,California ,United States ,San Francisco ,Phillipg Febbo ,Marc Stapley ,Genomic Health ,Duke University School Of Medicine ,Dana Farber Cancer Institute ,San Francisco Medical Center ,Veracyte Inc ,Reagan Udall Foundation ,Twitter ,University Of California ,Nasdaq ,Drug Administration ,Dartmouth College ,Names Phillip ,Chief Scientific Officer ,Chief Medical Officer ,Business Wire ,Duke University School ,Dana Farber Cancer ,Annual Report ,Quarterly Report ,Markets ,